Evidence map›Paper›PMID 21726211›Full record

ArticleClinical and experimental immunology2011

CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.

T S L Keesen, L R V Antonelli, D R Faria, L H Guimarães, O Bacellar, E M Carvalho, W O Dutra, K J Gollob

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Infection of Human Monocytes withFrontiers in immunology · 2017
    Article
  6. Review
  7. Article
  8. Article
  9. Proteome profiling of human cutaneous leishmaniasis lesion.The Journal of investigative dermatology · 2015
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

T S L KeesenDepartment of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
L R V Antonelli
D R Faria
L H Guimarães
O Bacellar
E M Carvalho
W O Dutra
K J Gollob
Complexo Hospitalar Universitário Professor Edgard Santos · BRInstituto Nacional de Ciência e Tecnologia de Doenças Tropicais · BRFundação Oswaldo Cruz · BRSanta Casa Hospital · BRSRI International · USUniversidade Federal de Minas Gerais · BR

Funding

DOUBLE NEGATIVE, CD4-CD8- T CELLS IN HUMAN LEISHMANIASISR03AI066253 · NIAID · UNIVERSIDADE FEDERAL DE MINAS GERAIS · PI GOLLOB, KENNETH J · 2008 to 2010
$161k
NIAID NIH HHS R03 AI066253NIAID NIH HHS R03AI066253-02
6 · The paper itself

Abstract

Leishmaniasis is caused by infection with the protozoan parasite, Leishmania, that parasitizes human cells, and the cellular immune response is essential for controlling infection. In order to measure the host T cell response to Leishmania infection, we have measured the expansion, activation state and functional potential of specific T cells as identified by their T cell receptor Vβ region expression. In a group of cutaneous leishmaniasis (CL) patients, we evaluated these characteristics in nine different T cell subpopulations as identified by their Vβ region expression, before and after specific Leishmania antigen stimulation. Our results show: (1) an increase in CD4(+) T cells expressing Vβ 5·2 and Vβ 24 in CL compared to controls; (2) a Leishmania antigen-induced increase in CD4(+) T cells expressing Vβ 5·2, 11, 12 and 17; (3) a profile of previous activation of CD4(+) Vβ 5·2-, 11- and 24-positive T cells, with higher expression of CD45RO, HLA-DR, interferon-γ, tumour necrosis factor-α and interleukin-10 compared to other Vβ-expressing subpopulations; (4) a positive correlation between higher frequencies of CD4(+) Vβ5·2(+) T cells and larger lesions; and (5) biased homing of CD4(+) T cells expressing Vβ 5·2 to the lesion site. Given that CL disease involves a level of pathology (ulcerated lesions) and is often followed by long-lived protection and cure, the identification of specific subpopulations active in this form of disease could allow for the discovery of immunodominant Leishmania antigens important for triggering efficient host responses against the parasite, or identify cell populations most involved in pathology.

Indexed as

AdolescentAdultAntigens, ProtozoanCD4 Lymphocyte CountCD4-Positive T-LymphocytesCell MovementCytokinesFemaleHLA-DR AntigensHumansInterferon-gammaInterleukin-10Leishmania braziliensisLeishmaniasis, CutaneousLeukocyte Common AntigensLeukocytes, MononuclearAntigens, ProtozoanCytokinesHLA-DR AntigensIL10 protein, humanInterferon-gammaInterleukin-10Leukocyte Common AntigensReceptors, Antigen, T-Cell, alpha-betaT cell receptor peptide Vbeta5.2Tumor Necrosis Factor-alpha

Identifiers

PMID21726211
PMCPMC3170983
OpenAlexW1776893163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.